IP Verse

Pharmaceutical Compositions Of Roflumilast In Aqueous Blends Of Water-Miscible, Pharmaceutically Acceptable Solvents

Patent No. EP3684334 (titled "Pharmaceutical Compositions Of Roflumilast In Aqueous Blends Of Water-Miscible, Pharmaceutically Acceptable Solvents") was filed by Arcutis on Sep 19, 2018. The application was issued on Dec 6, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
TEVA PHARMACEUTICALSAug 13, 2024ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3684334

ARCUTIS
Application Number
EP18783250A
Filing Date
Sep 19, 2018
Status
Granted And Under Opposition
Nov 3, 2023
Publication Date
Dec 6, 2023
External Links
Slate, Register , Google Patents